Lamisil and Depressed mood - a phase IV clinical study of FDA data

Summary:

Depressed mood is reported as a side effect among people who take Lamisil (terbinafine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Melatonin, and have Nail tinea.

The phase IV clinical study analyzes which people have Depressed mood when taking Lamisil. It is created by eHealthMe based on reports of 13,455 people who have side effects when taking Lamisil from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Depressed mood?

Depressed mood is found to be associated with 1,643 drugs and 1,540 conditions by eHealthMe. Check the latest studies of Depressed mood.

On Jul, 16, 2026

13,455 people reported to have side effects when taking Lamisil.
Among them, 36 people (0.27%) have Depressed mood.

Among these 36 people:

How long have people been on Lamisil when they have Depressed mood? *

What is the gender of people who have Depressed mood when taking Lamisil? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Depressed mood when taking Lamisil? *

What are other drugs people take besides Lamisil? *

What are other side effects people have besides Depressed mood? *

Dizziness: 18 people, 50.00%
Fatigue (feeling of tiredness): 12 people, 33.33%
Stress And Anxiety: 10 people, 27.78%
Depression: 10 people, 27.78%
Weakness: 8 people, 22.22%
Fever: 7 people, 19.44%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 19.44%
Weight Decreased: 6 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 6 people, 16.67%
Itching: 5 people, 13.89%

What are the existing conditions these people have? *

Nail Tinea (fungal infection of nail): 5 people, 13.89%
Rashes (redness): 3 people, 8.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 8.33%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 8.33%
Skin Plaque (red, scaly patches to appear on the skin): 2 people, 5.56%
Skin Disorder (skin disease): 2 people, 5.56%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 2.78%
Erection Problems: 1 person, 2.78%
Athlete's Foot (a fungal infection affecting the skin between the toes): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and have Depressed mood?

- Check whether Depressed mood is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamisil:

Lamisil (14,080 reports)

Depressed mood treatments and more:

Depressed mood (65,927 reports)

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depressed mood:

Depressed mood (1,643 drugs)

Browse all the conditions that are associated with Depressed mood:

Depressed mood (1,540 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.